Title: Antibodies: will their star continue to rise?

Antibodies are having a huge impact in basic and translational research, but they are also in crisis. Francesca Lake investigates. Due to their high specificity and selectivity, antibodies hold great potential for use in the life sciences, in everything from basic research to diagnostics and therapeutics. Since the 1970s when Köhler and Milstein produced hybridoma monoclonal antibodies (mAbs) through the fusion of antibody-producing mouse spleen cells with an immortal myeloma cell line, multiple research projects have utilized antibodies and it has been estimated that there are over 300 companies offering 2 million antibodies for research purposes.

Click Here For Complete Article Text


   Person Information
   Application Sequencing
 541711 - Research and Development in Biotechnology                
 622110 - General Medical and Surgical Hospitals                
Company  Product  Process  Other  Subjects  Event  Event  Date  Location  Publication  Publication  Date Text  Descriptor

  • Biotechnology





  • BioTechniques


  • 5/1/2019


  • Article